Earnings History Data for ATAI Life Sciences N.V. (ATAI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ATAI Life Sciences N.V.
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | PM | ATAI | ATAI Life Sciences N.V. | 236.60 | -0.16 | -0.15 | -0.14 | ATAI Life Sciences GAAP EPS of -$0.16 in-line [11/13/2024 8:14 AM] |
1.38 | -0.08 (-5.48%) |
1.51 | 0.05 (3.42%) |
1.02 - 2.85 | 2,254,367 | 1,840,000 | 12,819 | ||
| 13-08-2024 | PM | ATAI | atai Life Sciences | 213.00 | -0.36 | -0.17 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.36, revenue of $0.27M [8/13/2024 7:51 AM] |
1.22 | -0.02 (-1.61%) |
1.23 | -0.01 (-0.81%) |
1.02 - 2.85 | 678,226 | 680,000 | 22,894 | ||
| 15-05-2024 | PM | ATAI | atai Life Sciences | 325.00 | -0.17 | -0.20 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.17 beats by $0.01 [5/15/2024 7:56 AM] |
2.04 | 0.13 (6.81%) |
1.94 | 0.03 (1.57%) |
1.02 - 2.85 | 1,531,764 | 640,000 | 25,788 | ||
| 28-03-2024 | PM | ATAI | atai Life Sciences | 287.00 | -0.12 | -0.17 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.12 beats by $0.04 [3/28/2024 7:18 AM] |
1.97 | 0.18 (9.78%) |
1.81 | 0.02 (1.12%) |
1.02 - 2.39 | 2,873,100 | 1,340,000 | 22,775 | ||
| 14-11-2023 | PM | ATAI | atai Life Sciences | 194.00 | -0.14 | -0.20 | 0.00 | ATAI Life Sciences GAAP EPS of $0.25 [11/14/2023 7:28 AM] |
1.25 | 0.10 (8.70%) |
1.21 | 0.06 (5.22%) |
1.05 - 3.65 | 499,495 | 460,000 | 5,112 | ||
| 10-08-2023 | PM | ATAI | atai Life Sciences | 291.00 | -0.21 | -0.21 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.21 in-line [8/10/2023 11:01 AM] |
1.72 | -0.04 (-2.27%) |
1.77 | 0.01 (0.57%) |
1.14 - 4.96 | 543,751 | 710,000 | 6,229 | ||
| 11-05-2023 | PM | ATAI | atai Life Sciences | 325.00 | -0.21 | -0.22 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.21 in-line, revenue of $0.04M [5/11/2023 9:23 AM] |
1.95 | -0.05 (-2.50%) |
2.00 | 0.0 (0.00%) |
1.14 - 4.96 | 534,385 | 660,000 | 4,909 | ||
| 24-03-2023 | PM | 7:00 AM ET (Mar 24) |
ATAI | atai Life Sciences | 194.00 | -0.28 | -0.23 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.28 misses by $0.05, revenue of $0.04M misses by $0.07M [3/24/2023 7:23 AM] |
1.25 | 0.06 (5.04%) |
1.22 | 0.03 (2.52%) |
1.14 - 5.60 | 828,240 | 990,000 | 2,884 | |
| 10-11-2022 | PM | 7:35 AM ET (Nov 10) |
ATAI | ATAI Life Sciences N.V. | 464.45 | -0.22 | -0.23 | -0.21 | ATAI Life Sciences GAAP EPS of -$0.22 beats by $0.01 [11/10/2022 7:56 AM] |
2.96 | 0.23 (8.64%) |
2.90 | 0.18 (6.62%) |
2.60 - 16.10 | 1,294,438 | 890,000 | 11,319 | |
| 15-08-2022 | PM | 6:55 AM ET (Aug 15) |
ATAI | ATAI Life Sciences N.V. | 625.25 | -0.24 | -0.22 | -0.31 | ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01 [8/15/2022 7:56 AM] |
3.76 | -0.21 (-5.29%) |
4.46 | -0.12 (-2.62%) |
3.68 - 12.42 | 14,481 | 20,000 | 5,966 | |
|
||||||||||||||||||
| 16-05-2022 | PM | 7:00 AM ET (May 16) |
ATAI | ATAI Life Sciences N.V. | 522.38 | -0.24 | -0.25 | 0.00 | ATAI Life Sciences GAAP EPS of -$0.24 in-line [5/16/2022 6:57 AM] |
4.04 | 0.40 (10.85%) |
3.67 | 0.03 (0.82%) |
3.05 - 22.91 | 911,550 | 1,160,000 | 5,225 | |
| 30-03-2022 | PM | 7:00 AM ET (Mar 30) |
ATAI | ATAI Life Sciences N.V. | 796.68 | -0.63 | -0.15 | 0.00 | ATAI Life Sciences GAAP EPS of -$1.21 misses by $0.44, revenue of $20.37M beats by $3.13M [3/30/2022 7:04 AM] |
5.33 | -0.09 (-1.75%) |
5.15 | -0.27 (-4.98%) |
4.62 - 22.91 | 1,222,485 | 930,000 | 6,635 | |
|
||||||||||||||||||
| 15-11-2021 | PM | 7:00 AM ET (Nov 15) |
ATAI | ATAI Life Sciences N.V. | 2,260 | -0.21 | -0.25 | 0.00 | ATAI Life Sciences EPS beats by $0.02 [11/15/2021 7:04 AM] |
12.87 | -2.05 (-13.74%) |
15.30 | 0.38 (2.55%) |
12.12 - 22.91 | 1,514,802 | 670,000 | 2,342 | |
| 16-08-2021 | PM | Before the open (Aug 16) |
ATAI | ATAI Life Sciences N.V. | 2,190 | -0.31 | -0.13 | 0.00 | ATAI Life Sciences EPS misses by $0.18 [8/16/2021 7:34 AM] |
14.75 | 1.13 (8.31%) |
13.00 | -0.62 (-4.54%) |
13.13 - 22.91 | 1,173,620 | 300,000 | 8,846 | |
|
||||||||||||||||||